NCT01236053 2017-07-06Cancer in Patients With Gabapentin (GPRD)GlaxoSmithKlineCompleted2,323,608 enrolled 86 charts
NCT01386580 2015-01-22An Open-label, Phase I/IIa, Dose Escalating Study of 2B3-101 in Patients With Solid Tumors and Brain Metastases or Recurrent Malignant Glioma.BBB-Therapeutics B.V.Phase 1/2 Completed84 enrolled